Meyers James R 4
4 · Arbutus Biopharma Corp · Filed May 26, 2022
Insider Transaction Report
Form 4
Meyers James R
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-25+41,000→ 41,000 totalExercise: $2.25From: 2022-05-25Exp: 2032-05-25→ Common Shares (41,000 underlying)
Footnotes (2)
- [F1]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on May 25, 2022, the date of the grant.
- [F2]The option is fully vested and exercisable as of the date of the grant.